1. Home
  2. Live Updates
  3. Pfizer biontech covid 19 vaccine

Live Breaking News & Updates on Pfizer biontech covid 19 vaccine

Stay informed with the latest breaking news from Pfizer biontech covid 19 vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pfizer biontech covid 19 vaccine and stay connected to the pulse of your community

Moderna's new COVID-19 vaccine shows promising results in Phase 3 trial, company says

Moderna has announced that its next-generation COVID-19 vaccine, mRNA-1283, has successfully met the primary endpoints of its Phase 3 clinical trial.

Cambridge , Cambridgeshire , United-kingdom , Canada , United-states , Health-medical-pharma , Moderna , Bancel , Nc- , Business-finance , Mrna-vaccine

COVID-19 numbers tick up at Rhode Island long-term care facilities

Rhode Island health officials said COVID-19 cases are on the rise at long-term care facilities in Rhode Island.

Rhode-island , United-states , Suzanne-bornschein , Rhode-island-department-of-health , World-health-organization , Rhode-island-department , Health-medical-pharma , Blue-cross-shield , Bluecross-blueshield-of-tennessee , Nc- , Covid-19-vaccine , Influenza-vaccine

First pediatric death from RSV reported in Wisconsin

The Wisconsin Department of Health Services (DHS) says the death of the child, whose age was not released, was a result of Respiratory Syncytial Virus (RSV).

Wisconsin , United-states , Tom-haupt , Respiratory-syncytial-virus , Diseases-epidemiologist-tom , Health-medical-pharma , Occupational-safety-and-health , Monoclonal-antibodies , Atypical-pneumonias , Nirsevimab , Influenza-vaccine

St. Luke's introduces new immunizations against flu, COVID-19 and RSV

According to a recent news release from St. Luke's, during the fall and winter seasons, the spread of respiratory viruses increases, including flu, COVID-19 and

United-states , Idaho , Boise , Centers-for-disease , Disease-control , Medicare-part , Health-medical-pharma , Luke , St-luke , St-luke-x27s-medical-center , Palivizumab

Experts say now is perfect time to get COVID19 vaccine before Thanksgiving

Local doctors are expecting COVID-19 cases to climb again in the Tri-State.

Cincinnati , Ohio , United-states , Kristin-coppage , Health-medical-pharma , Pfizer-biontech-covid-19-vaccine , Pfizer , Tri-state-generation-and-transmission-association , Nc- , Biontech , Covid-19-vaccine

New COVID-19 variant expected to become dominant strain this winter

Infectious disease specialists are now closely monitoring the newest COVID-19 variant.

Cincinnati , Ohio , United-states , Wilma-hancock , Ben-prewitt , Kroger-health , Centers-for-disease , Disease-control , Schedule-your , Booster-online , Health-medical-pharma , The-kroger-co-

RSV vaccine recommended during pregnancy as second option to protect newborns

U.S. health officials on Friday recommended RSV vaccinations for moms-to-be, a second new option to protect newborns from serious lung infections.

Pfizer , Grace-lee , United-states , Pfizer-inc- , Health-medical-pharma , Mandy-cohen , Vaccination , Immunization-during-pregnancy , Vaccine , Pfizer-biontech-covid-19-vaccine , Biotechnology

Top local stories we are following today

The Spindale Police Department confirms with News 13 that the suspect in a fatal shooting in Rutherford County is in custody. Very few details have been release

Kristy-kepley , Transylvania-county , Social-issues , Transylvania-university , Booster-dose , Moderna-covid-19-vaccine , Vaccination , Pfizer-biontech-covid-19-vaccine , Rna-vaccines , Vaccine , Centers-for-disease-control-and-prevention

Children ages 5-11 now eligible for Pfizer-BioNTech COVID-19 booster dose

OLYMPIA – Booster doses of the Pfizer-BioNTech vaccine are now available for children ages 5-11. The Washington State Department of Health (DOH) expanded booster dose eligibility to include everyone 5 and older following guidance and recommendations from the U.S.

Washington , United-states , Olympia , Umaira-shah , Johnson , Centers-for-disease , Pfizer , Drug-administration , Public-health-connection , Advisory-committee-on-immunization-practices , Washington-state-department-of-health , Washington-state-department

Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine. 

Peter-marks , Robertm-califf , Pfizer , Pfizer-inc , Us-department-of-health , Human-services , Drug-administration , Products-advisory-committee , Biologics-evaluation , Related-biological-products-advisory-committee , Clinical-research , Disease